They found that the HRs of dementia among users of metformin + pioglitazone were 0.56, 0.66, 0.69, and 0.98, respectively, when compared with metformin‐based use of sulfonylureas, acarbose, meglitinide, and insulin.31 The gene discussed is INS; the disease is dementia.